Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001209191-23-005333
Filing Date
2023-01-27
Accepted
2023-01-27 17:24:30
Documents
1
Period of Report
2023-01-19

Document Format Files

Seq Description Document Type Size
1 FORM 4/A SUBMISSION doc4a.html 4/A  
1 FORM 4/A SUBMISSION doc4a.xml 4/A 3989
  Complete submission text file 0001209191-23-005333.txt   5484
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Issuer) CIK: 0001322505 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address AVON PRODUCTS, INC. 1345 AVENUE OF THE AMERICAS NEW YORK NY 10105
Business Address
Harford Simon N.R. (Reporting) CIK: 0001443705 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-33451 | Film No.: 23564396